Publications by the researcher in collaboration with LAURA CABEZA MONTILLA (32)

2023

  1. Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review

    Pharmaceutics, Vol. 15, Núm. 7

  2. Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer

    Applied Sciences (Switzerland), Vol. 13, Núm. 4

2022

  1. Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer

    BioImpacts, Vol. 12, Núm. 6, pp. 515-531

2021

  1. Antitumor effect of the ethanolic extract from seeds of euphorbia lathyris in colorectal cancer

    Nutrients, Vol. 13, Núm. 2, pp. 1-17

  2. Nanomedicine to overcome multidrug resistance mechanisms in colon and pancreatic cancer: Recent progress

    Cancers, Vol. 13, Núm. 9

  3. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes

    Biomedicine and Pharmacotherapy, Vol. 133

  4. Temozolomide: An updated overview of resistance mechanisms, nanotechnology advances and clinical applications

    Current Neuropharmacology, Vol. 19, Núm. 4, pp. 513-537

  5. The antitumor activity of sodium selenite alone and in combination with gemcitabine in pancreatic cancer: An in vitro and in vivo study

    Cancers, Vol. 13, Núm. 13

2020

  1. Bengamide analogues show a potent antitumor activity against colon cancer cells: A preliminary study

    Marine Drugs, Vol. 18, Núm. 5

  2. Biomimetic magnetoliposomes as oxaliplatin nanocarriers: In vitro study for potential application in colon cancer

    Pharmaceutics, Vol. 12, Núm. 6, pp. 1-20

  3. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

    Journal of Biosciences, Vol. 45, Núm. 1

  4. Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery

    Artificial Cells, Nanomedicine and Biotechnology, Vol. 48, Núm. 1, pp. 1022-1035

2019

  1. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer

    Pharmacological Research, Vol. 141, pp. 451-465

  2. Double origin of the extensor hallucis longus muscle: a case report

    Surgical and Radiologic Anatomy, Vol. 41, Núm. 12, pp. 1421-1423

  3. Nanoformulations for glioblastoma multiforme: A new hope for treatment

    Future Medicinal Chemistry, Vol. 11, Núm. 18, pp. 2459-2481

  4. O6-methylguanine-DNA methyltransferase promoter methylation in patients with rectal adenocarcinoma after chemoradiotherapy treatment: Clinical implications

    Balkan Medical Journal, Vol. 36, Núm. 5, pp. 283-286

  5. Oxaliplatin–biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: An in vitro study

    Pharmaceutics, Vol. 11, Núm. 8

2018

  1. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 553-565

  2. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

    Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578

  3. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

    Journal of Pharmacy and Pharmacology, Vol. 70, Núm. 4, pp. 488-497